Financials in USD. Standardized financial statements.
A compact view of how Tandem Diabetes Care, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.01B | $940.20M | $747.72M | $801.22M | $702.80M | $498.83M | $362.31M | $183.87M | $107.60M | $84.25M |
| Revenue Growth? | +7.9% | +25.7% | -6.7% | +14.0% | +40.9% | +37.7% | +97.0% | +70.9% | +27.7% | 0.0% |
| Cost of Revenue? | $483.89M | $450.63M | $380.03M | $388.23M | $326.58M | $238.31M | $168.09M | $94.04M | $63.51M | $60.66M |
| Gross Profit? | $530.85M | $489.57M | $367.69M | $412.99M | $376.21M | $260.52M | $194.21M | $89.82M | $44.09M | $23.59M |
| Gross Margin? | +52.3% | +52.1% | +49.2% | +51.5% | +53.5% | +52.2% | +53.6% | +48.9% | +41.0% | +28.0% |
| Operating Expenses? | $608.97M | $588.70M | $600.92M | $505.83M | $353.56M | $268.48M | $210.93M | $134.45M | $107.04M | $101.64M |
| Operating Income? | -$78.12M | -$99.13M | -$233.23M | -$92.85M | $22.65M | -$7.96M | -$16.72M | -$44.63M | -$62.94M | -$78.05M |
| EBITDA? | -$174.70M | -$99.13M | -$196.46M | -$74.21M | $34.06M | -$13.03M | -$18.45M | -$109.16M | -$54.82M | -$72.27M |
| Income Before Tax | -$200.27M | -$91.87M | -$220.25M | -$92.85M | $15.90M | -$36.28M | -$24.60M | -$122.56M | -$73.03M | -$83.46M |
| Income Tax Expense | $4.44M | $4.16M | $2.36M | $1.74M | $335,000 | -$1.90M | $149,000 | $51,000 | $8,000 | -$15,000 |
| Net Income? | -$204.71M | -$96.03M | -$222.61M | -$94.59M | $15.57M | -$34.38M | -$24.75M | -$122.61M | -$73.03M | -$83.45M |
| EPS? | $-3.04 | $-1.47 | $-3.43 | $-1.47 | $0.25 | $-0.56 | $-0.42 | $-2.55 | $-12.86 | $-27.30 |
| Diluted EPS? | $-3.04 | $-1.47 | $-3.43 | $-1.47 | $0.24 | $-0.56 | $-0.42 | $-2.55 | $-12.86 | $-27.30 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality